Latest market headlines for CONCORDBIO on Terminal.
18-Sept-2026 10:22:37
• USFDA conducted an inspection at the company's Unit II-Valthera formulation facility. • The inspection was successfully concluded on September 18, 2026. • US…
20-Jun-2026 18:35:04
• Concord Biotech to invest ₹6.3 Crores for 27.38% equity share capital in FSGE Renewable Power Private Limited. • FSGE is setting up a hybrid renewable energy…
12-Jun-2026 19:06:13
CONCORD BIO ; Concord Biotech Secures Abbreviated New Drug Application (ANDA) Approval For Tofacitinib Tablets, 5 Mg And 10 Mg
12-Jun-2026 19:06:10
• 🇧🇷 Successfully completed ANVISA (Brazilian Health Regulatory Agency) inspection at its Limbasi API manufacturing facility • 📅 Inspection was conducted fr…